GL1X · GenesisL1 explorer

MolNFT v1 · #122401 · protein

Crystal structure of recombinant human Z alpha-1-antitrypsin

5IO1: “Crystal structure of recombinant human Z alpha-1-antitrypsin”. X-ray diffraction, 1 ligand (NAG), 6 pockets (best druggability 0.80). MolNFT v1 #122401 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5IO1
Type
protein
Length
729 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-1-antitrypsin
UniProt
P01009
Ligands
NAG
Pockets
6 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-1-antitrypsinprotein36528% helix, 31% strandP01009
BAlpha-1-antitrypsinprotein36429% helix, 32% strandP01009

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18740.800.8383empty
21620.570.8227empty
3600.500.8625empty
4710.500.8424empty
51170.380.7418empty

Interfaces

1 interface between chains.

  • A–B · 950 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 glycan (N-glycosylation).

Compared structures

  • 5IO1 · Crystal structure of recombinant human Z alpha-1-antitrypsin · the same entry in another collection · chain A against A, TM-score 1.00
  • P01009 · AlphaFold monomer V2.0 prediction for alpha-1-antitrypsin (P01009) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.